Patient advocacy organizations dedicated to lymphedema awareness, treatment access, and research funding are achieving meaningful policy and clinical practice impacts in multiple countries, driving reimbursement improvements, clinical guideline development, professional education investments, and research funding allocations that are collectively improving the lymphedema care landscape for...